ASX - By Stock
|
RMD |
Re:
Ann: ResMed Announces Results for the Second Quarter of FY2024
|
|
Ashmen
|
41 |
22K |
4 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
41
|
22K
|
4
|
|
ASX - By Stock
|
RMD Medicine |
Re:
Buy RMD now and get great upside returns in a year or two
|
|
Ashmen
|
189 |
105K |
0 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
189
|
105K
|
0
|
|
Charts
|
CSL |
Re:
CSL Chart
|
|
Ashmen
|
1.1K |
652K |
3 |
04/01/23 |
04/01/23 |
Charts
|
1.1K
|
652K
|
3
|
|
ASX - By Stock
|
CSL |
Re:
News: CSL CSL Behring Will Begin Commercializing Hemgenix Immediately In The U.S. With A List Price...
|
|
Ashmen
|
18 |
6.6K |
3 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
18
|
6.6K
|
3
|
|
ASX - By Stock
|
BTA |
Re:
Prospectus to raise up to $125 Million
|
|
Ashmen
|
7 |
3.1K |
0 |
02/07/15 |
02/07/15 |
ASX - By Stock
|
7
|
3.1K
|
0
|
|
ASX - By Stock
|
BTA |
Re:
Prospectus to raise up to $125 Million
|
|
Ashmen
|
7 |
3.1K |
0 |
28/06/15 |
28/06/15 |
ASX - By Stock
|
7
|
3.1K
|
0
|
|
ASX - By Stock
|
BTA |
Re:
Prospectus to raise up to $125 Million
|
|
Ashmen
|
7 |
3.1K |
2 |
27/06/15 |
27/06/15 |
ASX - By Stock
|
7
|
3.1K
|
2
|
|
ASX - By Stock
|
BTA |
how to value bta?
|
|
Ashmen
|
0 |
248 |
3 |
26/12/13 |
26/12/13 |
ASX - By Stock
|
0
|
248
|
3
|
|
ASX - By Stock
|
BTA |
Re:
is it too late
|
|
Ashmen
|
11 |
489 |
7 |
22/04/11 |
22/04/11 |
ASX - By Stock
|
11
|
489
|
7
|
|